These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 24048783)
1. Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma? Bayraktar UD; Chen E; Bayraktar S; Sands LR; Marchetti F; Montero AJ; Rocha-Lima CM Cancer; 2011 Jun; 117(11):2364-70. PubMed ID: 24048783 [TBL] [Abstract][Full Text] [Related]
2. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis. Ejaz A; Casadaban L; Maker AV J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636 [TBL] [Abstract][Full Text] [Related]
3. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada. Lima IS; Yasui Y; Scarfe A; Winget M Cancer; 2011 Aug; 117(16):3833-40. PubMed ID: 21319156 [TBL] [Abstract][Full Text] [Related]
4. Survival and time interval from surgery to start of chemotherapy among colon cancer patients. Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115 [TBL] [Abstract][Full Text] [Related]
5. [Adjuvant chemotherapy for colon cancer]. Dahl O Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502 [TBL] [Abstract][Full Text] [Related]
6. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384 [TBL] [Abstract][Full Text] [Related]
7. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM; Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829 [TBL] [Abstract][Full Text] [Related]
8. Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer. Peixoto RD; Kumar A; Speers C; Renouf D; Kennecke HF; Lim HJ; Cheung WY; Melosky B; Gill S Clin Colorectal Cancer; 2015 Mar; 14(1):25-30. PubMed ID: 25465343 [TBL] [Abstract][Full Text] [Related]
10. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer. Hong KD; Lee SI; Moon HY Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527 [TBL] [Abstract][Full Text] [Related]
11. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea. Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187 [TBL] [Abstract][Full Text] [Related]
12. A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer. Schippinger W; Samonigg H; Schaberl-Moser R; Greil R; Thödtmann R; Tschmelitsch J; Jagoditsch M; Steger GG; Jakesz R; Herbst F; Hofbauer F; Rabl H; Wohlmuth P; Gnant M; Thaler J; Br J Cancer; 2007 Oct; 97(8):1021-7. PubMed ID: 17895886 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for stage III colon cancer: does timing matter? Czaykowski PM; Gill S; Kennecke HF; Gordon VL; Turner D Dis Colon Rectum; 2011 Sep; 54(9):1082-9. PubMed ID: 21825887 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer. Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445 [TBL] [Abstract][Full Text] [Related]
15. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753 [TBL] [Abstract][Full Text] [Related]
16. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy. Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812 [TBL] [Abstract][Full Text] [Related]
17. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer. Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer. Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117 [TBL] [Abstract][Full Text] [Related]
19. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer. McKenzie S; Nelson R; Mailey B; Lee W; Chung V; Shibata S; Garcia-Aguilar J; Kim J Cancer; 2011 Dec; 117(24):5493-9. PubMed ID: 21692068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]